| Number of patients | Mass type | Median age (IQR) | Postmenopausal (%) | Malignant (%) | Malignant, median age (IQR) |
---|---|---|---|---|---|---|
Second cohort (35 women) | 8 | Solid | 54 (9) | 6 (75.0%) | 7 (87.5%) | 54 (8) |
13 | Liquid | 42 (23) | 4 (30.8%) | 1 (7.7%) | 68 (0) | |
14 | Mixed | 54 (29) | 10 (71.4%) | 12 (85.7%) | 58 (23) |